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Genetic diversity of Plasmodium vivax clinical
isolates from southern Pakistan using pvcsp
and pvmsp1 genetic markers
Afsheen Raza1, Najia K Ghanchi1, Ali M Thaver2, Sana Jafri1 and Mohammad A Beg1*
Abstract
Background: Plasmodium vivax is the prevalent malarial species accounting for 70% of malaria burden in Pakistan;
however, there is no baseline data on the circulating genotypes. Studies have shown that polymorphic loci of gene
encoding antigens pvcsp and pvmsp1 can be used reliably for conducting molecular epidemiological studies.
Therefore, this study aimed to bridge the existing knowledge gap on population structure on P. vivax from Pakistan
using these two polymorphic genes.
Methods: During the period January 2008 to May 2009, a total of 250 blood samples were collected from patients
tested slide positive for P. vivax, at the Aga Khan University Hospital, Karachi, or its collection units located in
Baluchistan and Sindh Province. Nested PCR/RFLP was performed, using pvcsp and pvmsp1 markers to detect the
extent of genetic diversity in clinical isolates of P. vivax from southern Pakistan.
Results: A total of 227/250 (91%) isolates were included in the analysis while the remainder were excluded due to
negative PCR outcome for P.vivax. Pvcsp analysis showed that both VK 210 (85.5%, 194/227) and VK 247 type
(14.5%, 33/227) were found to be circulating in P. vivax isolates from southern Pakistan. A total of sixteen and
eighty-seven genotypes of pvcsp and pvmsp-1 were detected respectively.
Conclusion: This is the first report from southern Pakistan on characterization of P. vivax isolates confirming that
extensively diverse pvcsp and pvmsp1 variants are present within this region. Results from this study provide
valuable data on genetic diversity of P. vivax that will be helpful for further epidemiological studies.
Keywords: Malaria, Plasmodium vivax, Pakistan, Genetic diversity, Population structure, Circumsporozoite protein,
Merozoite surface protein 1
Background
Plasmodium vivax malaria is an important public health
problem causing an estimated 80–300 million clinical
infections annually [1]. In Pakistan it is the common
malarial species, contributing to 70% of the malaria bur-
den [2]. Although highly prevalent, P. vivax has received
scant scientific attention in Pakistan. Thus, paucity of
baseline data exists on various aspects of P. vivax, such
as population structure and drug resistance patterns.
Molecular epidemiological studies on genetic diversity
of P. vivax have been based mainly on single copy
polymorphic genes which code for parasite surface anti-
gens such as gametocyte antigen-1 (pvgam-1), circum-
sporozoite protein (csp), merozoite surface protein-1
(msp-1) and merozoite surface protein 3 alpha (msp 3α)
[3]. Briefly, CSP is a protein involved in binding of sporo-
zoite to liver cells [3-6]. It comprises of central domain of
tandem repeated sequences flanked by two non-repeated
conserved sequences [7-10]. Two types of repeat elements,
either VK210 or VK247 types are detected in clinical iso-
lates of P. vivax and thus csp serves as a useful tool for
genotyping [11,12]. Similarly, MSP-1 protein is responsible
for red cell invasion by the parasite [13]. Structurally, it is
a mosaic organization of 13 regions of inter-allele con-
served and extensively polymorphic variable blocks. Three
main regions of sequence divergence, at variable blocks 2,
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6–8 and 10 have been revealed through studies [14]. Size
polymorphisms in the respective blocks can be detected
through PCR, thus allowing detection of genetically dis-
tinct msp 1 populations within a region [15].
Molecular studies on circulating genotypes provide an
insight into transmission intensity and parasite rate vari-
ation within a region. Usually, in areas of high malaria
transmission, extensive genetic diversity is observed [16,17].
However, no study as yet has been reported on genetic di-
versity and transmission intensity of P. vivax from southern
Pakistan. This study aims to provide baseline epidemio-
logical data on circulating pvcsp and pvmsp 1 allelic var-
iants from three malaria-endemic areas of southern
Pakistan, i e, Karachi, Baluchistan and Sindh.
Methods
Study design, settings and ethical considerations
A descriptive study for detection of P. vivax allelic var-
iants was carried out between January 2008 and May
2009. A total of 250 patients, presenting with microscopy
confirmed asexual P. vivax mono-infection at Aga Khan
University Hospital, Karachi or its collection units located
in Sindh and Baluchistan Provinces were enrolled in the
study. The study was approved by the Ethical Review
Committee of Aga Khan University Hospital, Karachi.
Informed consent was obtained from enrolled patients or
in the case of children, from their parents/legal guardians.
Pregnant women, children under three years, and those not
consenting to participate were excluded from the study.
Blood collection and microscopy
Approximately 2 ml of intravenous blood sample in
EDTA tube was collected. Initial presence of malaria
parasites was established by Leishman’s staining [18]
while further species identification was determined by
Giemsa staining of thick and thin blood smears. Patients
with microscopically confirmed P. vivax infection were
included in the study. The remaining blood was stored
at -80°C until DNA extraction.
DNA extraction and amplification
DNA was extracted from 200 μl of whole blood using
QiAamp DNA Mini Kit (QIAGEN, USA) according to
manufacturer’s instructions. Nested PCR was performed
for central repetitive domain (VK 210 or VK 247 type)
of pvcsp and variable blocks 2, 6–8 and 10 (designated
as F1, F2 and F3 respectively) of pvmsp1 described previ-
ously [15]. Briefly, all amplification reactions were carried
out in a total volume of 20 μl in the presence of 10 Mm
Tris–HCl pH 8.3, 50 Mm KCL, 250 nM of each specific
oligonucleotide primers,125 μM of each of the four dNTPs
and 0.4 units of Taq polymerase (Invitrogen, USA). One μl
of genomic and amplified DNA was used for primary and
nested amplification reactions respectively. The cycling
parameters were as follows: initial denaturation at 95°C for
5 min, followed by annealing at defined temperatures for
each primer pair for 2 min, extension at 72°C for 2 min,
denaturation at 94°C for 1 min and final annealing step fol-
lowed by extension for 5 min [15]. Analysis of PCR pro-
ducts was done by gel electrophoresis. Briefly, amplified
product was loaded on 2% agarose gels alongside 100 bp
molecular weight marker, separated in TBE buffer by
electrophoresis, stained with ethidium bromide and
visualized under UV transilluminator (Gel Doc, Bio-Rad,
Hercules, USA).
PCR/RFLP
PCR/ RFLP was performed for pvcsp and pvmsp 1 F2 frag-
ment as described previously [15]. Briefly, amplified pro-
ducts were digested separately with restriction enzymes,
Alu I and Bst NI for pvcsp and Alu1 and Mnl1 for pvmsp1
F2 in a total volume of 20 μl for 3 hrs according to the
supplier’s specifications (New England Biolabs Inc., UK)
The digested product was analysed on 1.5% agarose gel
following ethidium bromide staining.
Identification of recurrent infections using pvmsp1 marker
For identification of recrudescence, relapse/new infec-
tions, pvmsp1 amplified products from recurrence sam-
ples was run side by side on agarose gel alongside 100
bp molecular weight marker. Band sizes were deter-
mined using Quantity one software (Biorad, Hercules,
USA). Recrudescence, relapse/ new infections were iden-
tified on the basis of differences/similarities in genotypes
[19-21].
Statistical analysis and allele detection
Data was entered in Microsoft Excel and exported to
SPSS 19.0 for analysis. Arithmetical means and medians
were calculated, where applicable, for all continuous
baseline demographic variables. Pvcsp repeat types were
detected on the basis of digestion with the respective re-
striction enzymes [15]. For determination of size poly-
morphisms, Quantity One software (Biorad, Hercules,
USA) was used. Further analysis of number of genotypes
and size polymorphisms in pvmsp1 F1, F2, F3 and pvcsp
was done by grouping the electrophoresis band sizes
into “bins” differing by 20 bp. The median genotype of
each fragment was identified. The absolute size of the
identified median band +/− 10 bp formed the initial bin.
Thereafter, each 20 bp interval below and above the me-
dian band were defined as representing a distinct geno-
type [22,23].
Results
Baseline demographic data
A total of 250 patients with microscopy-confirmed P. vivax
mono-infection were enrolled from Karachi, Baluchistan
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and rural areas of Sindh Province. Out of these, 227 (91%)
were included in the analysis while the remaining 23 (9.2%)
were excluded due to negative PCR outcome for P. vivax.
Baseline demographics of patients included in the analysis
are presented in Table 1.
Distribution of pvcsp repeats types
PCR RFLP analysis of pvcsp genetic marker revealed that
out of 227 isolates, 194 (85.5%) and 33 (14.5%) har-
boured parasite populations carrying VK 210 and VK
247 repeat types respectively while mixed genetic infec-
tion (both VK210 and VK 247) was observed in four
(1.8%) of the isolates. Base pair ranges of VK210 were
620-800bp and 680-820bp for VK247 type. A total of 16
genotypes (9 for VK210 and 7 for VK 247) were detected
on the basis of size variation in the repeat types.
VK 210 type was found to be predominant in Karachi
(87.4%, 160/183), Baluchistan (60.8%, 14/23) and Sindh
(95.2%, 20/21) while the percent positivity of VK 247 type
was found to be 12.5% in Karachi, 39% in Baluchistan and
4.8% in Sindh Furthermore, mixed genetic infection was
observed only in Karachi (2.2%)(Figure 1).
Pvmsp 1 allelic diversity
Length polymorphism was assessed within three main
regions of sequence divergence (F1, F2 and F3) in pvmsp
1 in all three study areas. Thirty-six genotypes were
observed in Karachi, 28 in Baluchistan and 23 in Sindh.
Thus, a total of 87 distinct genotypes were observed in
southern Pakistan. The geographical distribution of F1,
F2 and F3 variants with base pair ranges is given in
Table 2. Mixed genotype infections were observed fre-
quently in F1, F2 and F3 fragments in Karachi, F2 and
F3 fragments in Baluchistan and only in F3 fragment in
Sindh (Table 2). The mean multiplicity of infection was
calculated to be 1.1 for Karachi and 1.2 for Baluchistan
and Sindh.
For pvmsp1 F2 fragment, a total of 88 isolates (Karachi =
64, Baluchistan = 12, Sindh = 12) were analysed by RFLP
for further distinction of allelic variants. In Karachi, two
Mnl 1 and four Alu 1 patterns, in Baluchistan one Mnl 1
and three Alu 1 patterns while in Sindh, one Mnl 1 and
one Alu 1 pattern were observed. Therefore, combining
data from both size polymorphism and RFLP, a total of 28
distinct F2 variants could be differentiated in Karachi,
Baluchistan and Sindh respectively.
Identification of recurrent infections
A total of four cases, all from Karachi, were identified as
recrudescence or relapse/new infections using pvmsp1
marker. One case, re-admitted after 1month, revealed
the same genotype as that identified earlier while the
remaining three cases, re-infected after 6–8 months
showed different genotype than the earlier samples and
was thus regarded as relapse/new infection.
Discussion
This is the first study on genetic diversity of P. vivax
clinical isolates from southern Pakistan and the results
reveal that extensively diverse P. vivax populations are
present in this region. By using pvcsp genetic marker,
both VK210 and VK 247 types were found in parasite
population from southern Pakistan with VK210 being
the predominant type. However, the percent positivity of
VK 247 type (14.5%) is close to the findings from Herat,
Afghanistan (10.4%) [24] and south-eastern areas of Iran
(17.5%) [25] but different from that reported from
Northern Belt (FATA region) of Pakistan (2.7%) [26].
With respect to study areas, a similar pattern was
observed with VK 247 type percent positivity being high
in Baluchistan (39%) and Karachi (12.5%) but not in
Sindh Province (4.8%). This sharp difference in the fre-
quency of VK 247 type between southern and northern
regions of Pakistan and between the respective study
areas may be attributed to a number of factors such as
co distribution of various vector species and subse-
quently increased susceptibility of these species to infec-
tion by VK 247 type, sampling biases, migration rates,
host immune pressure and regional temporal fluctua-
tions [25,27]. It is possible that these factors, either alone
Table 1 Baseline characteristics of enrolled patients
All
(n = 227)
Karachi
(n = 183)
Baluchistan
(n = 23)
Sindh
(n = 21)
Age
5-15 years 43 30 3 10
> 15 years 184 153 20 11
Sex
Male 167 131 20 16
Female 60 52 3 5
Figure 1 Distribution of pvcsp types in Karachi, Baluchistan
and Sindh province.
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or in conjunction with each other may be allowing grad-
ual natural selection of VK 247 type, particularly in
Baluchistan and Karachi.
A total of 16 allelic variants of pvcsp types were observed
on the basis of size polymorphisms which is consistent with
15-21varients types observed in previous studies [5,28].
However, other studies from Thailand and India reported
ten and three variants respectively [15,27]. Studies suggest
that specific variant type infecting an individual may influ-
ence induced immune responses [29-31]. Therefore, detec-
tion of diverse VK 210 and VK 247 types in this study may
serve as a baseline for conducting further studies to under-
stand the role of these variants in host response.
With pvmsp1, a total of 87 distinct genotypes could be
distinguished through size polymorphisms in southern
Pakistan (Table 2). With respect to F1, F2 and F3 frag-
ments, 23, 41 and 23 allelic variants were detected in the
three study areas respectively, indicating that extensive
polymorphism has accumulated in msp-1 gene, particu-
larly in F2 fragment. This result is inconsistent with that
reported from Thailand and India [15,27], in which the
F2 fragment was found to be poorly polymorphic, with
two allelic variants detected through size polymorphism
and further distinction of F2 variants required RFLP
analysis. The results of this investigation revealed that
the F2 fragment in P. vivax isolates from Pakistan, is ex-
tensively polymorphic and can be genotyped easily using
PCR only with no further allelic distinction through
RFLP. However, further studies on F2 fragment from dif-
ferent areas of Pakistan and with larger sample size, is
required to corroborate these results. Moreover, mixed
genotype infections were observed frequently in all the
three msp-1 fragments in Karachi, F2 and F3 fragments
in Baluchistan and only in F3 fragment in Sindh
(Table 2). The F3 mixed variants were observed predom-
inantly in all three study areas indicating the predispos-
ition of this block to mixed infections. Such high rate of
mixed infections and prevalence of genetically diverse iso-
lates signifies that pvmsp-1 gene is under selective pres-
sure for its survival and transmission in Pakistan. This
finding is important with respect to transmission intensity
and surveillance of P. vivax in southern Pakistan.
The ability to detect genetically diverse variants in all
the three fragments of pvmsp1 signifies that this marker
can serve useful in identification of individual’s infec-
tions. In P. falciparum, recrudescence is identified when
the genotype pattern for the two paired samples of a
study participant is the same or any bands are shared be-
tween the two samples, while a new infection is indicated
when the patterns are completely different [32]. Studies
suggest that similar strategy can be used for identification
of relapses/recrudescence in P. vivax. However, distinction
between relapse and recrudescence is difficult due to the
high variability in the genotypes of parasite during relapse/
recurrence/new infections [19-21]. In this study, three
relapses and one recrudescence case has been identified
on the basis of differences/similarities in the pvmsp-1
genetic marker. However, extensive polymorphism in
P. vivax and small number of relapse samples collected
during this study suggests interpretation of recurrent in-
fection with caution.
Molecular characterization on population structure of
P. vivax isolates from southern Pakistan has been explored
for the first time in this study. The extensive polymorph-
ism and diversity observed in pvcsp and pvmsp1 genetic
markers is indicative of natural selective pressure on the
parasite for its survival and transmission in the region.
However, further studies from different areas of Pakistan
are needed to determine the prevalent genotypes and the
transmission intensity of P. vivax. Results from this study
can serve as a baseline for conducting studies for effective
malaria control.
Conclusion
Increased sequence variation is observed in P. vivax, sig-
nifying the high transmission rates and consequently the
difficulties associated with malaria control in Pakistan.
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Table 2 Geographical distribution of pvmsp 1 genotypes
with base pair ranges
Base pair
ranges
No. of
genotypes
No. of mixed
variants
Karachi
F1 320-550 10 6
F2 900-1270 16 4
F3 200-400 10 11
Baluchistan
F1 330-550 8 0
F2 960-1270 14 1
F3 200-320 6 3
Rural Sindh
F1 340-460 5 0
F2 930-1190 11 0
F3 200-350 7 5
Total no. of genotypes 87
F1 = Fragment 1 representing variable block 2, F2 = Fragment 2 represents
variable block 6–8, F3 = Fragment 3 representing variable block 10.
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